DIFFERENTIAL EFFECT OF THE CALMODULIN INHIBITOR TRIFLUOPERAZINE IN MODULATING CELLULAR ACCUMULATION, RETENTION AND CYTO-TOXICITY OF DOXORUBICIN IN PROGRESSIVELY DOXORUBICIN-RESISTANT L1210 MOUSE LEUKEMIA-CELLS - LACK OF CORRELATION BETWEEN CELLULAR DOXORUBICIN LEVELS AND EXPRESSION OF RESISTANCE

被引：41

作者：

GANAPATHI, R

GRABOWSKI, D

机构：

来源：

BIOCHEMICAL PHARMACOLOGY | 1988年 / 37卷 / 02期

关键词：

D O I：

10.1016/0006-2952(88)90716-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：185 / 193

页数：9

相关论文

共 34 条

[11] GANAPATHI R, 1984, CANCER RES, V44, P5056
[12] GOLDIN A, 1975, CANCER CHEMOTH REP 3, V6, P137
[13] FUNCTIONAL-ROLE FOR THE 170-KDA TO 180-KDA GLYCOPROTEIN SPECIFIC TO DRUG-RESISTANT TUMOR-CELLS AS REVEALED BY MONOCLONAL-ANTIBODIES
HAMADA, H
TSURUO, T
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (20) : 7785 - 7789
[14] HARKER WG, 1986, CANCER RES, V46, P2369
[15] ISOQUINOLINESULFONAMIDES, NOVEL AND POTENT INHIBITORS OF CYCLIC-NUCLEOTIDE DEPENDENT PROTEIN-KINASE AND PROTEIN KINASE-C
HIDAKA, H
INAGAKI, M
KAWAMOTO, S
SASAKI, Y
[J]. BIOCHEMISTRY, 1984, 23 (21) : 5036 - 5041
[16] INABA M, 1979, CANCER RES, V39, P2200
[17] UPTAKE AND RETENTION OF ADRIAMYCIN AND DAUNORUBICIN BY SENSITIVE AND ANTHRACYCLINE-RESISTANT SUBLINES OF P388-LEUKEMIA
INABA, M
JOHNSON, RK
[J]. BIOCHEMICAL PHARMACOLOGY, 1978, 27 (17) : 2123 - 2130
[18] JOHNSON RK, 1978, CANCER TREAT REP, V62, P1535
[19] KESSEL D, 1986, CANCER SURV, V5, P109
[20] KESSEL D, 1985, CANCER RES, V45, P1687

← 1 2 3 4 →